Company Information

  

Address: 7801 N CAPITAL OF TEXAS HIGHWAY
SUITE 260 
City: AUSTIN 
State: TX 
Zip Code: 78731 
Telephone: 512-501-2444 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Pain Therapeutics, Inc. develops proprietary drugs that offer significant improvements to patients and healthcare professionals. We generally focus our drug development efforts on disorders of the nervous system, such as chronic pain. Our expertise consists of developing new drug candidates and guiding these through various regulatory and development pathways in preparation for their eventual commercialization. By necessity, the conduct of drug development is complex, lengthy, expensive and risky. The FDA has not yet established the safety or efficacy of our drug candidates. For over a decade, we have pioneered technology, tools and techniques that enable the development of Abuse-Deterrent Formulations, or ADFs. ADFs are intended to make opioid drugs difficult to abuse yet provide steady pain relief when used appropriately by patients. ADFs are intended to help in the fight against prescription drug abuse.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/2017-1.87NAN/E
06/2017-2.02NAN/E
03/2017-12.74NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.09Total Liab/Total Assets0.03
Net Inc/Total Assets-0.77Total Liab/Inv Cap0.04
Net Inc/Inv Cap-0.80Total Liab/Comm Equity0.00
Pretax Inc/Net SalesNAInterest Coverage RatioNA
Net Inc/Net SalesNACurr Debt/EquityNA
Cash Flow/Net SalesNALTD/EquityNA
SG&A/NetSalesNATotal Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio28.68
Inventory TurnoverNACurrent Ratio28.68
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  9/30/2017 6/30/2017 3/31/2017 12/31/2016
Total Revenues(Net Sales) NA NA NA NA
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 0.98 1.10 1.38 1.21
Operating Income -2.60 -4.17 -2.76 -2.54
Interest Exp NA NA NA NA
Pretax Income -2.59 -4.16 -2.74 -2.52
Other Income 0.01 0.01 0.02 0.02
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -2.59 -4.16 -2.74 -2.52

Balance Sheet (Millions)

Assets 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Cash & Short Term Investments 11.92 14.07 17.26 18.71
Receivables - Total NA NA NA NA
Inventories - Total NA NA NA NA
Total Current Assets 12.20 14.08 17.39 19.07
Net Property, Plant & Equipment 0.17 0.19 0.21 0.23
Total Assets 12.38 14.27 17.60 19.30
Liabilities        
Accounts Payable 1.01 1.00 0.88 0.67
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 1.01 1.00 0.88 0.67
Long-Term Debt NA NA NA NA
Total Liabilities 1.01 1.00 0.88 0.67
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.01 0.01 0.05 0.05
Retained Earnings -154.98 -152.39 -148.23 -145.49
Treasury Stock NA NA NA NA
Total Stockholders' Equity 11.37 13.27 16.72 18.64
Total Liabilities and Stockholders' Equity 12.38 14.27 17.60 19.30

Cash Flow Summary (Millions)

Categories 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Net Cash Provided by Operating Activities -2.15 -3.20 -1.45 -3.03
Net Cash Provided by Investing Activities 0.00 0.00 2.10 -1.54
Net Cash Provided by Financing Activities 0.00 0.00 0.00 -0.02

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201210.89-3.45--
12/201341.1231.54--
12/20140.00-12.39--
12/20150.00-14.14--
12/20160.00-14.85--
Growth Rates-100.00----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17342,37135.96




Report Date : 12/11/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.